Moderna Sues Pfizer and BioNTech Over COVID Vaccine

August 26, 2022 by Dan McCue
Moderna Sues Pfizer and BioNTech Over COVID Vaccine
This Sept. 21, 2021, file photo shows vials of the Pfizer and Moderna COVID-19 vaccines in Jackson, Miss. (AP Photo/Rogelio V. Solis, File)

CAMBRIDGE, Mass. — Pharma giant Moderna sued Pfizer and BioNTech on Friday, claiming that their popular COVID vaccine was copied from groundbreaking science Moderna performed.

In a statement posted on its website, Moderna said Pfizer and BioNTech infringed on patents it filed between 2010 and 2016 involving mRNA, a kind of genetic code that directs how cells produce certain proteins.

Like the computer code that makes Windows or any other software work, mRNA is the key to the efficacy of the COVID vaccines.

“When COVID-19 emerged, neither Pfizer nor BioNTech had Moderna’s level of experience with developing mRNA vaccines for infectious diseases, and they knowingly followed Moderna’s lead in developing their own vaccine,” Moderna claims.


“First, Pfizer and BioNTech took four different vaccine candidates into clinical testing, which included options that would have steered clear of Moderna’s innovative path,” it continues. Pfizer and BioNTech, however, ultimately decided to proceed with a vaccine that has the same exact mRNA chemical modification to its vaccine as Spikevax®. 

“Moderna scientists began developing this chemical modification that avoids provoking an undesirable immune response when mRNA is introduced into the body in 2010 and were the first to validate it in human trials in 2015,” it says.

Stéphane Bancel, Moderna’s chief executive, said in a written statement that the company filed its lawsuits against Pfizer and BioNTech in the federal court in Boston and the Regional Court of Düsseldorf in Germany, “to protect the innovative mRNA technology platform that we pioneered, invested billions of dollars in creating, and patented during the decade preceding the COVID-19 pandemic.” 

“This foundational platform … enabled us to produce a safe and highly effective COVID-19 vaccine in record time after the pandemic struck,” Bancel said.


In October 2020, Moderna pledged not to enforce its COVID-19 related patents while the pandemic continued. In March, however, the company updated its position. It said that since the “collective fight against COVID” had “entered a new phase” in which vaccine supply was no longer a barrier to access, it expected companies such as Pfizer and BioNTech to respect its intellectual property rights and reach an agreement on a “commercially reasonable license.” 

Pfizer and BioNTech, Moderna says, have failed to do that.

“We believe that Pfizer and BioNTech unlawfully copied Moderna’s inventions, and they have continued to use them without permission,” said Moderna Chief Legal Officer Shannon Thyme Klinger. “Outside of AMC 92 countries, where vaccine supply is no longer a barrier to access, Moderna expects Pfizer and BioNTech to compensate Moderna for the ongoing use of Comirnaty®, [one of] Moderna’s patented technologies. 

“Our mission to create a new generation of transformative medicines for patients by delivering on the promise of mRNA science cannot be achieved without a patent system that rewards and protects innovation,” Klinger added.

The AMC 92 countries to which she is referring are the 92 low- and middle-income economies eligible to get access to COVID-19 vaccines through the Gavi Vaccine Alliance, an independent group founded through a partnership of the World Health Organization, UNICEF, the World Bank and the Bill & Melinda Gates Foundation.

Moderna on Friday said that it was not seeking damages for activities before March 8 and that it was not seeking to remove Pfizer and BioNTech’s vaccines from the market.

It also said that it was not asking for an injunction to prevent its future sale, given the need for access to coronavirus vaccines.


A spokeswoman for Pfizer said Friday morning that the company had not yet been served with the lawsuit and therefore could not comment on it.

Dan can be reached at [email protected] and at https://twitter.com/DanMcCue.

A+
a-

In The News

Health

Voting

Litigation

March 14, 2023
by Dan McCue
Ohio Sues Norfolk Southern Over East Palestine Derailment

COLUMBUS, Ohio — The state of Ohio filed a 58-count civil lawsuit against Norfolk Southern Tuesday, seeking to hold the... Read More

COLUMBUS, Ohio — The state of Ohio filed a 58-count civil lawsuit against Norfolk Southern Tuesday, seeking to hold the Class 1 railroad financially responsible for the Feb. 3 derailment in East Palestine that caused the release of an estimated 1 million gallons of hazardous chemicals.... Read More

March 14, 2023
by Tom Ramstack
Afghan, Iraqi Refugees Complain Delayed Visas Threaten Lives

WASHINGTON — Afghan and Iraqi refugees accused the Biden administration in a court filing last week of creating too many... Read More

WASHINGTON — Afghan and Iraqi refugees accused the Biden administration in a court filing last week of creating too many new obstacles to their residency in the United States. The plaintiffs were translators for the U.S. military. They say they face retaliation from the Taliban and... Read More

March 14, 2023
by Dan McCue
Calif. Court Says Uber, Lyft, Can Still Treat Drivers as Contractors

SAN FRANCISCO — Uber, Lyft and other companies with ride-sharing apps can continue to treat their drivers as independent contractors,... Read More

SAN FRANCISCO — Uber, Lyft and other companies with ride-sharing apps can continue to treat their drivers as independent contractors, a California appeals court ruled Monday, overturning a lower court decision. At issue was California’s Proposition 22, which state voters approved in November 2020, and which... Read More

Michael Cohen to Testify Monday in Trump Hush-Money Probe

NEW YORK (AP) — Donald Trump’s former lawyer and fixer Michael Cohen is scheduled to testify Monday before a Manhattan... Read More

NEW YORK (AP) — Donald Trump’s former lawyer and fixer Michael Cohen is scheduled to testify Monday before a Manhattan grand jury investigating hush-money payments made on the former president’s behalf, two people familiar with the matter told The Associated Press. They were not authorized to speak... Read More

Fox Libel Defense at Odds With Top GOP Presidential Foes

NEW YORK (AP) — Fox News is on an unlikely collision course with two leading contenders for the Republican presidential... Read More

NEW YORK (AP) — Fox News is on an unlikely collision course with two leading contenders for the Republican presidential nomination over the rights of journalists. In defending itself against a massive defamation lawsuit over how it covered false claims surrounding the 2020 presidential election, the network is... Read More

March 2, 2023
by Dan McCue
DOJ Argues Trump Not Immune From Jan. 6 Liability Claims

WASHINGTON — Former President Donald Trump should not be able to claim executive immunity from liability claims arising from the... Read More

WASHINGTON — Former President Donald Trump should not be able to claim executive immunity from liability claims arising from the Jan. 6, 2021, siege on the U.S. Capitol, the Justice Department said in a court filing on Thursday. The filing is the latest development in consolidated... Read More

News From The Well
scroll top